Our Team



Ann McKee, MD, Professor of Neurology and Pathology, Director of the Boston University Alzheimer’s Disease Center Neuropathology Core, Director of VA-BU-SLI Brain Brank, and Neuropathologist of National VA ALS Brain Bank and National PTSD Brain Bank

Thor Stein, M.D., PhD, Assistant Professor of Pathology and Laboratory Medicine and Associate Director of the Neuropathology Core of the Boston University Alzheimer’s Disease Center

Victor E. Alvarez, MD, Physician Research Associate

Jesse Mez, MD, MS, Assistant Professor of Neurology

Todd Solomon, PhD, Clinical Neuropsychology Fellow

Clinical Research Team:

Daniel H. Daneshvar, MA, MD/PhD Candidate

Patrick Kiernan, Research Assistant

Katharine Babcock, Research Assistant

Lisa McHale, Director of Family Relations at the Sports Legacy Institute

Jason Miller, Administrative Manager

Pathology Research Team:

Kerry Cormier, Senior Neuropathology Technician

Carol Kubilus, Senior Neuropathology Technician

Rebecca Mathias, Senior Neuropathology Technician


Lee Goldstein, MD, PhD, Associate Professor, Biomedical Engineering, Associate Professor, Psychiatry, Neurology, Opthalmology, Pathology and Laboratory Medicine, Director, Molecular Aging and Development Laboratory, Director, Translation Core, NIH Alzheimer’s Disease Center, Director, Center for Biometals & Metallomics (CBM), Director, Molecular Biophotonics Laboratory (MBL)

Doug Katz, MD, Professor of Neurology

Neil Kowall, MD, Professor of Neurology and Pathology and Director of the Boston University Alzheimer’s Disease Center

Chris Nowinski, Co-Founder and Executive Director of the Sports Legacy Institute

Robert A. Stern, PhD, Professor of Neurology and Neurosurgery and Director of the Boston University Alzheimer’s Disease Center Clinical Core

Concussion Legacy Foundation is a 501(c)(3) non-profit dedicated to the study, treatment and prevention of concussions and Chronic Traumatic Encephalopathy (CTE), a progressive degenerative brain disease caused by repetitive concussive and sub-concussive brain injuries. The organization was conceived after SLI members and their colleagues identified the first four cases of CTE in retired professional football players. At the time of their deaths, all four athletes, all of whom died by the age of 50, had remarkable early cell death and excessive amounts of the toxic protein tau throughout their brains, indicative of CTE.